Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

4.8%

1 terminated/withdrawn out of 21 trials

Success Rate

94.4%

+7.9% vs industry average

Late-Stage Pipeline

24%

5 trials in Phase 3/4

Results Transparency

6%

1 of 17 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
6(42.9%)
Phase 4
4(28.6%)
Phase 2
3(21.4%)
Phase 3
1(7.1%)
14Total
N/A(6)
Phase 4(4)
Phase 2(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (21)

Showing 20 of 21 trials
NCT05047315Completed

Evaluating a New Stool Based qPCR for Diagnosis of Tuberculosis in Children and People Living With HIV

Role: collaborator

NCT05124691Phase 2Terminated

Evaluation of Effectiveness of ALBENDAZOLIVERMECTIN Coformulation vs ALBENDAZOLE for Treatment of Intestinal Worms

Role: collaborator

NCT05343312Phase 4Completed

In Vivo Efficacy of Artemether-Lumefantrine, Amodiaquine-Artesunate, Dihydroartemisinin-Piperaquine, and Pironaridine-Artesunate in Mozambique

Role: lead

NCT06970600Not ApplicableCompleted

Efficacy of Artemether-Lumefantrine in the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Children Under 12 Years at Four Sentinel Sites in Mozambique

Role: lead

NCT04825327Completed

Predicting the Future: Incipient Tuberculosis

Role: collaborator

NCT05306067Completed

Plasmodium Falciparum Genomic Intelligence in Mozambique

Role: lead

NCT06529237Recruiting

Malaria Molecular Surveillance in Mozambique (Phase 2)

Role: lead

NCT02694874Not ApplicableCompleted

Rosiglitazone Adjunctive Therapy for Severe Malaria in Children

Role: lead

NCT05228639Completed

COVID-19 Surveillance in Rural Mozambique for Prompt and Effective Response

Role: lead

NCT04826718Completed

SARS-CoV-2/COVID-19 Infection Among Health Care Workers

Role: collaborator

NCT04641858Phase 4Completed

BCG to Reduce Absenteeism Among Health Care Workers During the COVID-19 Pandemic

Role: collaborator

NCT02910934Not ApplicableCompleted

Cost-effectiveness Evaluation of Vector Control Strategies in Mozambique

Role: collaborator

NCT04370977Phase 4Completed

In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate in Mozambican Children (MEFI_III)

Role: lead

NCT01911494Not ApplicableCompleted

Community Level Interventions for Pre-eclampsia

Role: collaborator

NCT02698748Phase 2Completed

Evaluating the Role of Chloroquine for Malaria Elimination

Role: lead

NCT02914145Not ApplicableCompleted

Mass Drug Administrations of DHA-PQP to Accelerate Towards Malaria Elimination in Magude District, Southern Mozambique

Role: lead

NCT02199951Unknown

Introduction of Eurartesim® in Burkina Faso, Mozambique, Ghana and Tanzania

Role: collaborator

NCT02168569Phase 4Completed

In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate in Mozambican Children

Role: lead

NCT00811421Not ApplicableCompleted

Evaluation of Alternative Antimalarial Drugs for Malaria in Pregnancy

Role: collaborator

NCT00393679Phase 3Completed

Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children

Role: collaborator